, VS -data analysis, preparation of the manuscript; AV -sample collection, critical review of the manuscript; CD -sample collection, critical review of the manuscript; CG -design of the study, preparation of the manuscript, work
, SP -design of the study
Multilineage potential of adult human mesenchymal stem cells, Science, vol.284, issue.5411, pp.143-150, 1999. ,
Mesenchymal Stem Cells: Time to Change the Name! Stem Cells Transl Med, vol.6, pp.1445-51, 2017. ,
Mesenchymal stem cells as trophic mediators, J Cell Biochem, vol.98, issue.5, pp.1076-84, 2006. ,
Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances, Ann Biomed Eng, vol.32, issue.1, pp.160-165, 2004. ,
Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium, Stem Cells Int, p.698076, 2013. ,
Undifferentiated mesenchymal stem cells seeded on a vascular prosthesis contribute to the restoration of a physiologic vascular wall, J Vasc Surg, vol.47, issue.6, pp.1313-1334, 2008. ,
Mesenchymal stem cells: from experiment to clinic, Fibrogenesis Tissue Repair, vol.4, issue.20, 2011. ,
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells, Blood, vol.108, issue.12, pp.3938-3982, 2006. ,
Mesenchymal stem cells: a double-edged sword in regulating immune responses, Cell Death Differ, vol.19, issue.9, pp.1505-1518, 2012. ,
Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice, Proc Natl Acad Sci, vol.102, issue.50, pp.18171-18177, 2005. ,
New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation, Int J Stem Cells, vol.8, issue.1, pp.54-68, 2015. ,
Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages, Dev Reprod, vol.21, issue.1, pp.1-10, 2017. ,
Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo, Stem Cells, vol.33, issue.6, pp.1818-1846, 2015. ,
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart, Circulation, vol.105, issue.1, pp.93-101, 2002. ,
Oxygen in stem cell biology: a critical component of the stem cell niche, Cell Stem Cell, vol.7, issue.2, pp.150-61, 2010. ,
Hypoxiainducible mir-210 regulates normoxic gene expression involved in tumor initiation, Mol Cell, vol.35, issue.6, pp.856-67, 2009. ,
The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning, Can J Cardiol, vol.25, issue.6, pp.353-361, 2009. ,
Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells, Stem Cells, vol.26, issue.8, pp.2173-82, 2008. ,
Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients, Cardiovasc Res, vol.101, issue.2, pp.266-76, 2014. ,
Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway, Mol Ther, vol.18, issue.8, pp.1545-52, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00509086
Inducible metabolic adaptation promotes mesenchymal stem cell therapy for ischemia: a hypoxia-induced and glycogen-based energy prestorage strategy, Arterioscler Thromb Vasc Biol, vol.34, issue.4, pp.870-876, 2014. ,
Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury, Clin Sci (Lond), vol.124, issue.3, pp.165-76, 2013. ,
Strategies to Enhance Implantation and Survival of Stem Cells After Their Injection in Ischemic Neural Tissue, Stem Cells Dev, vol.26, issue.8, pp.554-65, 2017. ,
Combined mild hypoxia and bone marrow mesenchymal stem cells improve expansion and HOXB4 gene expression of human cord blood CD34+ stem cells, Arch Biol Sci, vol.3, pp.433-474, 2018. ,
Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain, Stem Cell Res, vol.3, issue.2-3, pp.142-56, 2009. ,
To harness stem cells by manipulation of energetic metabolism, Transfus Clin Biol, vol.24, issue.4, pp.468-71, 2017. ,
The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches, Tissue Eng Part B Rev, vol.16, issue.2, pp.159-68, 2010. ,
Benefits of hypoxic culture on bone marrow multipotent stromal cells, Am J Blood Res, vol.2, issue.3, pp.148-59, 2012. ,
Hypoxia and stem cell-based engineering of mesenchymal tissues, Biotechnol Prog, vol.25, issue.1, pp.32-42, 2009. ,
miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay, Science, vol.336, issue.6078, pp.237-277, 2012. ,
A parsimonious model for gene regulation by miRNAs, Science, vol.331, issue.6017, pp.550-553, 2011. ,
Small RNAs: miRNA machinery disposal, Nat Rev Mol Cell Biol, vol.14, issue.1, pp.4-5, 2013. ,
microRNAs: important regulators of stem cells, Stem Cell Res Ther, vol.8, issue.1, p.110, 2017. ,
miR-210: fine-tuning the hypoxic response, Adv Exp Med Biol, vol.772, pp.205-232, 2014. ,
Treating cancer with microRNA replacement therapy: A literature review, J Cell Physiol, vol.233, issue.8, pp.5574-88, 2018. ,
MicroRNA therapeutics: principles, expectations, and challenges, Chin J Cancer, vol.30, issue.6, pp.368-70, 2011. ,
Developing microRNA therapeutics, Circ Res, vol.110, issue.3, pp.496-507, 2012. ,
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3, J Biol Chem, vol.283, issue.23, pp.15878-83, 2008. ,
Targeting miRNAs in osteoblast differentiation and bone formation, Expert Opin Ther Targets, vol.14, issue.10, pp.1109-1129, 2010. ,
MiR-210--micromanager of the hypoxia pathway, Trends Mol Med, vol.16, issue.5, pp.230-237, 2010. ,
Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1, J Vet Sci, vol.14, issue.1, pp.69-76, 2013. ,
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis, Br J Cancer, vol.108, issue.5, pp.1133-1175, 2013. ,
Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression, Oncogene, vol.29, issue.30, pp.4362-4370, 2010. ,
MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2, Cell Metab, vol.10, issue.4, pp.273-84, 2009. ,
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT, Cell Cycle, vol.8, issue.17, pp.2756-68, 2009. ,
Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2, J Biol Chem, vol.284, issue.48, pp.33161-33169, 2009. ,
Mesenchymal stem cells and hypoxia: where are we? Mitochondrion, vol.19, pp.105-117, 2014. ,
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, issue.4, pp.315-322, 2006. ,
, FEBS Lett, vol.581, pp.3582-91, 2007.
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1, Biochem J, vol.405, issue.1, pp.1-9, 2007. ,
Transcriptional regulation by hypoxia inducible factors, Crit Rev Biochem Mol Biol, vol.49, issue.1, pp.1-15, 2014. ,
HIF-1 and HIF-2: working alone or together in hypoxia?, J Clin Invest, vol.117, issue.4, pp.862-867, 2007. ,
Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition, J Cell Biochem, vol.112, issue.3, pp.804-821, 2011. ,
Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha, J Biol Chem, vol.279, issue.15, pp.14871-14879, 2004. ,
The hypoxia-associated factor switches cells from HIF-1alpha-to HIF-2alpha-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion, Cancer Res, vol.71, issue.11, pp.4015-4042, 2011. ,
Passing the baton: the HIF switch, Trends Biochem Sci, vol.37, issue.9, pp.364-72, 2012. ,